Alembic Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the exchanges that the trading window for dealing in its shares will be closed from 1st July 2025 until 48 hours after the declaration of its unaudited financial results for the quarter ended 30th June 2025 (Q1 FY26). This is a standard compliance measure under SEBI's Insider Trading Regulations, during which designated persons and their immediate relatives cannot trade in the company's securities. The date of the board meeting to approve the Q1 results will be communicated later. The filing was signed by Company Secretary Manisha Saraf on 26th June 2025.
This is a routine regulatory filing and not a material event. It signals that Q1 FY26 earnings are upcoming, which investors should watch for as it may impact short-term stock movement. No immediate action is required from shareholders.